Your browser doesn't support javascript.
loading
A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy.
Kastrati, Irida; Siklos, Marton I; Brovkovych, Svitlana D; Thatcher, Gregory R J; Frasor, Jonna.
Afiliação
  • Kastrati I; Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, E202 MSB, MC90, Chicago, IL, 60612, USA. ikastr2@uic.edu.
  • Siklos MI; Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Brovkovych SD; Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, E202 MSB, MC90, Chicago, IL, 60612, USA.
  • Thatcher GRJ; Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Frasor J; Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, E202 MSB, MC90, Chicago, IL, 60612, USA. jfrasor@uic.edu.
Horm Cancer ; 8(3): 135-142, 2017 06.
Article em En | MEDLINE | ID: mdl-28396978
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / NF-kappa B / Antineoplásicos Hormonais Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / NF-kappa B / Antineoplásicos Hormonais Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article